Contribution of N-methyl-D-aspartate receptors to attention and episodic spatial memory during senescence

Neurobiology of Learning and Memory

Volumn 125, Issue , 2015, Pages 36-46

  Guidi, Michael ^b   Rani, Asha ^a   Karic, Semir ^a   Severance, Barrett ^a   Kumar, Ashok ^a   Foster, Thomas C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Noldus Information Technology bv   (Netherlands)

Author keywords

Aging; Attention; Episodic memory; Hippocampus; MK 801; NMDA receptor; Prefrontal cortex

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE;

ADULT; AGE; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DELAYED MATCHING TO POSITION TEST; EPISODIC MEMORY; EXPERIMENTAL BEHAVIORAL TEST; FIVE CHOICE SERIAL REACTION TIME TASK; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MIDDLE AGED; NONHUMAN; PREFRONTAL CORTEX; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SPATIAL MEMORY; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; COGNITION; DRUG EFFECTS; FISCHER 344 RAT; PHYSIOLOGY; REACTION TIME;

AGING; ANIMALS; ATTENTION; BEHAVIOR, ANIMAL; COGNITION; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMORY, EPISODIC; RATS; RATS, INBRED F344; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; SPATIAL MEMORY;

EID: 84938699855     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2015.07.015     Document Type: Article

References (85)

1. Aenlle K.K., Foster T.C. Aging alters the expression of genes for neuroprotection and synaptic function following acute estradiol treatment. Hippocampus 2010, 20:1047-1060.
2. Aitken D.H., Meaney M.J. Temporally graded, age-related impairments in spatial memory in the rat. Neurobiology of Aging 1989, 10:273-276.
3. Albert M.S. Changes in cognition. Neurobiology of Aging 2011, 32(Suppl. 1):S58-S63.
4. Alexander G.E., Ryan L., Bowers D., Foster T.C., Bizon J.L., Geldmacher D.S., et al. Characterizing cognitive aging in humans with links to animal models. Frontiers in Aging Neuroscience 2012, 4:21.
5. Aracava Y., Pereira E.F., Maelicke A., Albuquerque E.X. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics 2005, 312:1195-1205.
6. Bannerman D.M., Niewoehner B., Lyon L., Romberg C., Schmitt W.B., Taylor A., et al. NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28:3623-3630.
7. Benn A., Robinson E.S. Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task. PloS One 2014, 9:e115374.
8. Bizon J.L., LaSarge C.L., Montgomery K.S., McDermott A.N., Setlow B., Griffith W.H. Spatial reference and working memory across the lifespan of male Fischer 344 rats. Neurobiology of Aging 2009, 30:646-655.
9. Blalock E.M., Chen K.C., Sharrow K., Herman J.P., Porter N.M., Foster T.C., et al. Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:3807-3819.
10. Bloss E.B., Janssen W.G., Ohm D.T., Yuk F.J., Wadsworth S., Saardi K.M., et al. Evidence for reduced experience-dependent dendritic spine plasticity in the aging prefrontal cortex. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31:7831-7839.
11. Cabeza R., Daselaar S.M., Dolcos F., Prince S.E., Budde M., Nyberg L. Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval. Cerebral Cortex 2004, 14:364-375.
12. Carey R.J., Dai H., Gui J. Effects of dizocilpine (MK-801) on motor activity and memory. Psychopharmacology 1998, 137:241-246.
13. Creeley C., Wozniak D.F., Labruyere J., Taylor G.T., Olney J.W. Low doses of memantine disrupt memory in adult rats. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006, 26:3923-3932.
14. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Annals of Neurology 1990, 27:457-464.
15. Dewachter I., Filipkowski R.K., Priller C., Ris L., Neyton J., Croes S., et al. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiology of Aging 2009, 30:241-256.
16. Driscoll I., Howard S.R., Stone J.C., Monfils M.H., Tomanek B., Brooks W.M., et al. The aging hippocampus: A multi-level analysis in the rat. Neuroscience 2006, 139:1173-1185.
17. Ferris S., Schneider L., Farmer M., Kay G., Crook T. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). International Journal of Geriatric Psychiatry 2007, 22:448-455.
18. Foster T.C. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 2007, 6:319-325.
19. Foster T.C. Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca(2)(+) channels in senescent synaptic plasticity. Progress in Neurobiology 2012, 96:283-303.
20. Foster T.C., Barnes C.A., Rao G., McNaughton B.L. Increase in perforant path quantal size in aged F-344 rats. Neurobiology of Aging 1991, 12:441-448.
21. Foster T.C., Defazio R.A., Bizon J.L. Characterizing cognitive aging of spatial and contextual memory in animal models. Frontiers in Aging Neuroscience 2012, 4:12.
22. Foster T.C., Kumar A. Susceptibility to induction of long-term depression is associated with impaired memory in aged Fischer 344 rats. Neurobiology of Learning and Memory 2007, 87:522-535.
23. Foster T.C., Norris C.M. Age-associated changes in Ca(2+)-dependent processes: Relation to hippocampal synaptic plasticity. Hippocampus 1997, 7:602-612.
24. Foster T.C., Sharrow K.M., Masse J.R., Norris C.M., Kumar A. Calcineurin links Ca2+ dysregulation with brain aging. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:4066-4073.
25. Frankiewicz T., Potier B., Bashir Z.I., Collingridge G.L., Parsons C.G. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. British Journal of Pharmacology 1996, 117:689-697.
26. Gaspar P.A., Bustamante M.L., Silva H., Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: Therapeutic implications. Journal of Neurochemistry 2009, 111:891-900.
27. Gleichmann M., Zhang Y., Wood W.H., Becker K.G., Mughal M.R., Pazin M.J., et al. Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks. Neurobiology of Aging 2012, 33(205):e201-e218.
28. Gouzoulis-Mayfrank E., Heekeren K., Neukirch A., Stoll M., Stock C., Obradovic M., et al. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 2005, 38:301-311.
29. Guidi M., Kumar A., Foster T.C. Impaired attention and synaptic senescence of the prefrontal cortex involves redox regulation of NMDA receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2015, 35:3966-3977.
30. Guidi M., Kumar A., Rani A., Foster T.C. Assessing the emergence and reliability of cognitive decline over the life span in Fisher 344 rats using the spatial water maze. Frontiers in Aging Neuroscience 2014, 6:2.
31. Harati H., Majchrzak M., Cosquer B., Galani R., Kelche C., Cassel J.C., et al. Attention and memory in aged rats: Impact of lifelong environmental enrichment. Neurobiology of Aging 2011, 32:718-736.
32. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nature Reviews Neuroscience 2010, 11:682-696.
33. Higgins G.A., Ballard T.M., Enderlin M., Haman M., Kemp J.A. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat. Psychopharmacology 2005, 179:85-98.
34. Holahan M.R., Taverna F.A., Emrich S.M., Louis M., Muller R.U., Roder J.C., et al. Impairment in long-term retention but not short-term performance on a water maze reversal task following hippocampal or mediodorsal striatal N-methyl-D-aspartate receptor blockade. Behavioral Neuroscience 2005, 119:1563-1571.
35. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:11496-11500.
36. Honey R.A., Turner D.C., Honey G.D., Sharar S.R., Kumaran D., Pomarol-Clotet E., et al. Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2003, 28:2037-2044.
37. Ingram D.K., Garofalo P., Spangler E.L., Mantione C.R., Odano I., London E.D. Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Research 1992, 580:273-280.
38. Jackson M.E., Homayoun H., Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8467-8472.
39. Jodo E., Suzuki Y., Katayama T., Hoshino K.Y., Takeuchi S., Niwa S., et al. Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway. Cerebral Cortex 2005, 15:663-669.
40. Jones D.N., Barnes J.C., Kirkby D.L., Higgins G.A. Age-associated impairments in a test of attention: Evidence for involvement of cholinergic systems. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1995, 15:7282-7292.
41. Kesner R.P., Dakis M. Phencyclidine injections into the dorsal hippocampus disrupt long- but not short-term memory within a spatial learning task. Psychopharmacology 1995, 120:203-208.
42. Kornhuber J., Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neuroscience Letters 1995, 195:137-139.
43. Kotecha S.A., Oak J.N., Jackson M.F., Perez Y., Orser B.A., Van Tol H.H., et al. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 2002, 35:1111-1122.
44. Kumar A., Foster T.C. Linking redox regulation of NMDAR synaptic function to cognitive decline during aging. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2013, 33:15710-15715.
45. Kumar A., Rani A., Tchigranova O., Lee W.H., Foster T.C. Influence of late-life exposure to environmental enrichment or exercise on hippocampal function and CA1 senescent physiology. Neurobiology of Aging 2012, 33(828):828.e1-828.e17.
46. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:796-807.
47. Lee I., Kesner R.P. Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory. Nature Neuroscience 2002, 5:162-168.
48. Lee W.H., Kumar A., Rani A., Foster T.C. Role of antioxidant enzymes in redox regulation of N-methyl-D-aspartate receptor function and memory in middle-aged rats. Neurobiology of Aging 2014, 35:1459-1468.
49. Lee W.H., Kumar A., Rani A., Herrera J., Xu J., Someya S., et al. Influence of viral vector-mediated delivery of superoxide dismutase and catalase to the hippocampus on spatial learning and memory during aging. Antioxidants & Redox Signaling 2012, 16:339-350.
50. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nature Reviews Drug Discovery 2006, 5:160-170.
51. Mabry T.R., McCarty R., Gold P.E., Foster T.C. Age and stress history effects on spatial performance in a swim task in Fischer-344 rats. Neurobiology of Learning and Memory 1996, 66:1-10.
52. McDonald R.J., Hong N.S., Craig L.A., Holahan M.R., Louis M., Muller R.U. NMDA-receptor blockade by CPP impairs post-training consolidation of a rapidly acquired spatial representation in rat hippocampus. European Journal of Neuroscience 2005, 22:1201-1213.
53. McHugh T.J., Jones M.W., Quinn J.J., Balthasar N., Coppari R., Elmquist J.K., et al. Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network. Science 2007, 317:94-99.
54. Means L.W., Kennard K.J. Working memory and the aged rat: Deficient two-choice win-stay water-escape acquisition and retention. Physiology & Behavior 1991, 49:301-307.
55. Molina L.A., Skelin I., Gruber A.J. Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex. PloS One 2014, 9:e85842.
56. Morris R.G., Steele R.J., Bell J.E., Martin S.J. N-methyl-d-aspartate receptors, learning and memory: Chronic intraventricular infusion of the NMDA receptor antagonist d-AP5 interacts directly with the neural mechanisms of spatial learning. European Journal of Neuroscience 2013, 37:700-717.
57. Morrison J.H., Baxter M.G. The ageing cortical synapse: Hallmarks and implications for cognitive decline. Nature Reviews Neuroscience 2012, 13:240-250.
58. Muir J.L., Fischer W., Bjorklund A. Decline in visual attention and spatial memory in aged rats. Neurobiology of Aging 1999, 20:605-615.
59. Nakamura Y., Kitamura S., Homma A., Shiosakai K., Matsui D. Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: Results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan. Expert Opinion on Pharmacotherapy 2014, 15:913-925.
60. Nakazawa K., Sun L.D., Quirk M.C., Rondi-Reig L., Wilson M.A., Tonegawa S. Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron 2003, 38:305-315.
61. Norris C.M., Foster T.C. MK-801 improves retention in aged rats: Implications for altered neural plasticity in age-related memory deficits. Neurobiology of Learning and Memory 1999, 71:194-206.
62. Papadia S., Soriano F.X., Leveille F., Martel M.A., Dakin K.A., Hansen H.H., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nature Neuroscience 2008, 11:476-487.
63. Pehrson A.L., Bondi C.O., Totah N.K., Moghaddam B. The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention. Psychopharmacology 2013, 225:31-39.
64. Povysheva N.V., Johnson J.W. Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons. Journal of Neurophysiology 2012, 107:2232-2243.
65. Rammes G., Rupprecht R., Ferrari U., Zieglgansberger W., Parsons C.G. The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neuroscience Letters 2001, 306:81-84.
66. Rammsayer T.H. Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. Learning & Memory 2001, 8:20-25.
67. Riepe M.W., Adler G., Ibach B., Weinkauf B., Tracik F., Gunay I. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Dementia and Geriatric Cognitive Disorders 2007, 23:301-306.
68. Rogawski M.A., Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Reviews 2003, 9:275-308.
69. Scheff S.W., Price D.A., Schmitt F.A., DeKosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
70. Schneider L.S., Dagerman K.S., Higgins J.P., McShane R. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Archives of Neurology 2011, 68:991-998.
71. Seeman P., Caruso C., Lasaga M. Memantine agonist action at dopamine D2High receptors. Synapse 2008, 62:149-153.
72. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:2866-2875.
73. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008, 14:837-842.
74. Smith J.W., Gastambide F., Gilmour G., Dix S., Foss J., Lloyd K., et al. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory. Psychopharmacology 2011, 217:255-269.
75. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nature Neuroscience 2005, 8:1051-1058.
76. Steele R.J., Morris R.G. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus 1999, 9:118-136.
77. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991, 30:572-580.
78. Turic D., Langley K., Mills S., Stephens M., Lawson D., Govan C., et al. Follow-up of genetic linkage findings on chromosome 16p13: Evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Molecular Psychiatry 2004, 9:169-173.
79. von Engelhardt J., Doganci B., Jensen V., Hvalby O., Gongrich C., Taylor A., et al. Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron 2008, 60:846-860.
80. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
81. Wang M., Yang Y., Wang C.J., Gamo N.J., Jin L.E., Mazer J.A., et al. NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron 2013, 77:736-749.
82. Wozniak D.F., Olney J.W., Kettinger L., Price M., Miller J.P. Behavioral effects of MK-801 in the rat. Psychopharmacology 1990, 101:47-56.
83. Wroolie T.E., Kenna H.A., Williams K.E., Powers B.N., Holcomb M., Lazzeroni L., et al. Cognitive effects of memantine in postmenopausal women at risk of dementia: A pilot study. Acta Neurologica Scandinavica 2009, 119:172-179.
84. Xi D., Zhang W., Wang H.X., Stradtman G.G., Gao W.J. Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2009, 12:1395-1408.
85. Zelikowsky M., Bissiere S., Hast T.A., Bennett R.Z., Abdipranoto A., Vissel B., et al. Prefrontal microcircuit underlies contextual learning after hippocampal loss. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:9938-9943.